NCT03971539View on ClinicalTrials.gov

Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

October 26, 2020

Study Completion Date

October 26, 2020

Conditions
Asthma
Interventions
DRUG

BI 894416

BI 894416 film-coated tablet.

DRUG

Placebo

Placebo film-coated tablet matching BI 894416.

Trial Locations (1)

30625

Fraunhofer ITEM, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03971539 - Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma | Biotech Hunter | Biotech Hunter